IGF1 and glioblastoma: Overexpression of IGF-1R has been linked to poorer survival in GBM patients [5,6] and IGF signaling was implicated in GBM resistance to chemotherapy [6] and to treatment with EGFR [7] and PDGFR [8] inhibitors.